| Financial Year |
March 31 2023 |
| Monetary Funds |
4,972,620,315.92 |
| Held-for-trading Financial Assets |
72,338,665.26 |
| Notes Receivable |
43,146,790.65 |
| Accounts Receivable |
1,371,732,596.33 |
| Advances to Suppliers |
392,279,202.56 |
| Other Receivables |
270,878,615.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
415,453,034.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
17,592,196.81 |
| Other Current Assets |
672,509,339.19 |
| Total Current Assets |
8,404,734,522.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
329,467,041.22 |
| Long-term Equity Investment |
856,057,797.77 |
| Investment Properties |
18,851,704,634.39 |
| Fixed Assetes |
2,818,096,978.94 |
| Under-construction Projects |
629,733,429.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
719,139,354.32 |
| R&D expenses |
49,186,906.24 |
| Goodwill |
4,363,290.03 |
| Long-Term Deferred and Prepaid Expenses |
1,478,044,546.21 |
| Deferred Income Tax Assets |
1,991,441,742.70 |
| Other Non-Current Assets |
2,902,188,263.93 |
| Sub-Total of Non-Current Assets |
45,198,238,851.96 |
| Total Assets |
53,602,973,374.63 |
| Short-Term Loans |
1,255,687,748.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
472,983,148.42 |
| Accounts Received In Advance |
997,398,670.07 |
| Employee Compensation Payable |
116,093,051.76 |
| Taxes Payable |
682,689,605.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,455,531,020.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,400,383,958.27 |
| Other Current Liabilities |
85,151,623.25 |
| Sub-Total of Current Liabilities |
8,989,535,163.34 |
| Long-term Loans |
2,382,530,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
917,791,738.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,059,842.18 |
| Deferred Income Tax Liabilities |
2,434,158,242.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,360,109,651.15 |
| Total Liabilities |
32,349,644,814.49 |
| Paid-In Capital(Or Share Stock) |
6,529,036,899.00 |
| Capital Surplus |
8,587,081,075.47 |
| Surplus Reserve |
356,055,813.24 |
| LESS:Treasury Stock |
340,730,121.08 |
| Undistributed Profits |
4,855,540,938.14 |
| Minority Stockholder's Interest |
1,007,541,873.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,245,786,686.67 |
| Owner's Equity（Stockholder's Equity） |
21,253,328,560.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
53,602,973,374.63 |
